• Home
  • About Us
  • Subscribe
  • Advertise
  • Newsroom
  • Sign In
  • Create Account
  • Sign Out
  • My Account
  • Current Issue
    • Latest News
    • Special Report
    • Up Close
    • Opinion
  • News by Sector
    • Real Estate & Construction
    • Banking & Finance
    • Health Care
    • Education & Talent
    • North Idaho
    • Technology
    • Manufacturing
    • Retail
    • Government
  • Roundups & Features
    • Calendar
    • People
    • Business Licenses
    • Q&A Profiles
    • Cranes & Elevators
    • Retrospective
    • Insights
    • Restaurants & Retail
  • Supplements & Magazines
    • Book of Lists
    • Building the INW
    • Market Fact Book
    • Economic Forecast
    • Best Places to Work
    • Partner Publications
  • E-Edition
  • Journal Events
    • Elevating the Conversation
    • Workforce Summit
    • Icons
    • Women in Leadership
    • Rising Stars
    • Best Places to Work
    • People of Influence
    • Business of the Year Awards
  • Podcasts
  • Sponsored
Home » Cholesterol, diabetes prescriptions lead drug spending for the elderly

Cholesterol, diabetes prescriptions lead drug spending for the elderly

May 6, 2010
News Wise

Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007, equating to about one-fourth of the approximately $82 billion spent for medications for the elderly, says the federal Agency for Healthcare Research and Quality (AHRQ).

Metabolic drugs, which are used to lower cholesterol levels, to keep diabetes under control, and to address weight and thyroid problems, topped the list of the five leading categories of drugs purchased by the elderly. The analysis by the federal agency found that the other four drug classes in the top five in 2007 were:

•Cardiovascular drugs, including blood pressure medicines, diuretics, and drugs to control abnormal heart rhythms, such as atrial fibrillation, at $15 billion.

•Central nervous system drugs, such as arthritis and other pain medications, $8 billion.

•Gastrointestinal drugs, which include antacid medications, $7 billion.

•Hormones, to treat osteoporosis, cancer, and other conditions, $5 billion.

The focus of AHRQ, which is part of the U.S. Department of Health and Human Services, is to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The data were reported in an AHRQ News and Numbers summary taken from the Medical Expenditure Panel Survey (MEPS), a detailed source of information on the health services used by Americans, the frequency with which they are used, the cost of those services, and how they are paid.

    Latest News
    • Related Articles

      Drug found to help lower risk of some ailments for women

      Hospital units for elderly found to reduce expenses

      Statins can do more than cut cholesterol

    News Wise

    Mayo Clinic seeks to dispel myths about ovarian cancer

    More from this author
    Daily News Updates

    Subscribe today to our free E-Newsletters!

    SUBSCRIBE

    Featured Poll

    What is Spokane's most iconic historic building?

    Popular Articles

    • Stephanie vigil web
      By Karina Elias

      Catching up with: former news anchor Stephanie Vigil

    • Rite aid3 web
      By Journal of Business Staff

      Two Spokane Rite Aid stores to close

    • 40.13 fc art
      By Tina Sulzle

      $165 million development planned at CDA National Reserve

    • Stcu ceo lindseymyhre web
      By Journal of Business Staff

      STCU names new president, CEO

    • Centennial lofts
      By Erica Bullock

      Large Spokane Valley residential project advances

    • News Content
      • News
      • Special Report
      • Up Close
      • Roundups & Features
      • Opinion
    • More Content
      • E-Edition
      • E-Mail Newsletters
      • Newsroom
      • Special Publications
      • Partner Publications
    • Customer Service
      • Editorial Calendar
      • Our Readers
      • Advertising
      • Subscriptions
      • Media Kit
    • Other Links
      • About Us
      • Contact Us
      • Journal Events
      • Privacy Policy
      • Tri-Cities Publications

    Journal of Business BBB Business Review allianceLogo.jpg CVC_Logo-1_small.jpg

    All content copyright ©  2025 by the Journal of Business and Northwest Business Press Inc. All rights reserved.

    Design, CMS, Hosting & Web Development :: ePublishing